A Phase 1/2 Study of TJO-083: A 5% Diquafosol Ophthalmic Formulation for the Treatment of Dry Eye Disease
Korean Journal of Ophthalmology · 10.08.2026
DOI: 10.3341/kjo.2026.0023 ↗Kurz gefasst
Fachartikel in der Zeitschrift Korean Journal of Ophthalmology, online erschienen am 10.08.2026. Verfasst von Hyung Keun Lee und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Vision Research, Department of Ophthalmology, Yonsei University College of Medicine, Seoul, South Korea. shadik@yuhs.ac.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Institute of Vision Research, Department of Ophthalmology, Yonsei University College of Medicine, Seoul, South Korea. shadik@yuhs.ac.
- Institute of Vision Research, Department of Ophthalmology, Yonsei University College of Medicine, Seoul, South Korea.
- Department of Ophthalmology, Korea University College of Medicine, Seoul, South Korea.
Zitieren
APA
Lee, H. K., Kim, T. I., & Song, J. S. (2026). A Phase 1/2 Study of TJO-083: A 5% Diquafosol Ophthalmic Formulation for the Treatment of Dry Eye Disease. Korean Journal of Ophthalmology. https://doi.org/10.3341/kjo.2026.0023
Vancouver
Lee HK, Kim TI, Song JS. A Phase 1/2 Study of TJO-083: A 5% Diquafosol Ophthalmic Formulation for the Treatment of Dry Eye Disease. Korean Journal of Ophthalmology. 2026. doi:10.3341/kjo.2026.0023
BibTeX
@article{Lee2026,
author = {Lee, Hyung Keun and Kim, Tae-Im and Song, Jong Suk},
title = {A Phase 1/2 Study of TJO-083: A 5% Diquafosol Ophthalmic Formulation for the Treatment of Dry Eye Disease},
journal = {Korean Journal of Ophthalmology},
year = {2026},
doi = {10.3341/kjo.2026.0023}
}
EUVIMED